ANDREA DOLISCHKA,CHRISTIAN GIEFFERS,FRANK MATTNER,MARKUS MANDLER,OLEKSANDR OTAVA
申请号：
BRPI0915137
公开号：
BRPI0915137A2
申请日:
2009.06.12
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to the use of mimotopes in the treatment of diseases associated with beta-amyloid formation and/or aggregation (beta-Amyloidoses) including Alzheimer's disease, whereby said mimotopes are able to induce the in vivo formation of antibodies directed to Abeta1-40/42, AbetapE3-40/42, Abeta3-40/42 and Abeta11-40/42.
